RENT.COM.AU LIMITED — Capital/Financing Update 2005

Nov 21, 2005

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 177/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.

Name of entity

Select Vaccines Limited

ABN

25 062 063 692

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

• $\mathbf{1}$ ⁺Class of ⁺securities issued or to be issued
• $\mathcal{I}$ Number of ⁺securities issued or to be issued (if known) or maximum number which may be issued
• Principal terms of the ⁺securities 3 (eg, if options, exercise price and date; if partly paid expiry *securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

$a$ Ordinary Shares b) Ordinary Shares

a) Up to $3,750,000$ ordinary shares (SLT) b) $Up$ to $10,827,826$ ordinary shares (SLT) via non-renouncable rights issue.

• Pari passu with existing ordinary a). shares, however will not participate in the pro-rata rights issue.
• b) Pari passu with existing ordinary shares

⁺ See chapter 19 for defined terms.

4	Do the securities rank equally in all respects from the date of allotment with an existing class of quoted *securities?			a) Yes (SLT) b) Yes (SLT)
	If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the ۰ next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
5	Issue price or consideration		a)	\$0.16 per share b) \$0.16 per share
6.	Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)			a) Placement issue	b) 1 for 4 non- renounceable pro-rata rights
7	Dates of entering "securities into uncertificated holdings or despatch of certificates	a)	b) To be advised	To be advised
		Number			+ Class
8	Number and class of all securities quoted on ASX (including the securities in clause 2 if applicable)	43,311,305*			Ordinary Shares (SLT) 4,000,000 subject tο voluntary escrow to 29 April 2007
		7,637,987			Options exercisable at \$0.80 on or before 1 February 2007 (SLTO)
		18,405,837			Options exercisable at \$0.20 on or before 31 May 2008 (SLTOA)
				*(These figures do not include the securities in clause 2 as it is not

yet applicable)

⁺ See chapter 19 for defined terms.

Number	+ Class
350,000	Options exercisable at \$0.20 on or before 30 June $2006$ (SLTAK)
2,570,000	Options exercisable at \$0.30 on or before 30 April 2008 (SLTAO)
1,000,000	Options exercisable at \$0.30 on or before 31 May 2008 (SLTAP)
500,000	Options exercisable at \$0.30 on or before 30 October - 2008 (SLTAQ)
2,000,000	Options exercisable at $$0.44$ on or before 29 April 2009 (SLTAS)
1,000,000	Options exercisable at \$0.435 on or before 29 April 2008 (SLTAU)

Dividend policy (in the case of a $\lceil \text{trust, distribution policy} \rceil$ on the $10₁₀$ increased capital (interests)

Unchanged

⁺ See chapter 19 for defined terms.

Part 2 - Bonus issue or pro rata issue

$\mathbf{1}$	approval security holder Īš required?	No
12	Is the issue renounceable or non- renounceable?	Non-renouncable
13	Ratio in which the "securities will be offered	$1$ for $4$
14	Class of securities to which the offer relates	Ordinary - ASX:SLT
15	*Record determine date to entitlements	1 December 2005
16	Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?	Yes
17	Policy for deciding entitlements in relation to fractions	Round up
18	Names of countries in which the entity has *security holders who will not be. sent new issue documents	To be sent to all shareholders
	Note: Security holders must be told how their entitlements are to be dealt with.
	Cross reference: rule 7.7.
19	Closing date for receipt οf acceptances or renunciations	19 December 2005

⁺ See chapter 19 for defined terms.

20.	Names of any underwriters	Taylor Collison Limited
21	Amount of any underwriting fee or commission
22	Names of any brokers to the issue	Taylor Collison Limited
23.	Fee or commission payable to the broker to the issue	\$103,947, or 6% of amount to be underwritten
24	of any handling fee Amount payable to brokers who lodge acceptances or renunciations on behalf of *security holders	None
25.	If the issue is contingent on *security holders' approval, the date of the meeting	Not applicable
26.	Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled	5 December 2005
27.	If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders	Not applicable
28.	Date rights trading will begin (if Not applicable applicable)
29.	Date rights trading will end (if Not applicable applicable)
30	How do *security holders sell their entitlements in full through a broker?	Not applicable
31	How do *security holders sell part of their entitlements through a broker and accept for the balance?	Not applicable

⁺ See chapter 19 for defined terms.

32 How do "security holders dispose of their entitlements (except by sale through a broker)?

33 *Despatch date Not applicable

22 December 2005

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34	Type of securities
	(tick one)

$(b)$

Securities described in Part 1 $(a)$

All other securities
----------------------	--

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35	If the "securities are "equity securities, the names of the 20 largest holders of the additional "securities, and the number and percentage of additional "securities held by those holders
36	If the "securities are "equity securities, a distribution schedule of the additional *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ 10,001 - 100,000 $100,001$ and over

	37 • A copy of any trust deed for the additional +securities

$+$ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

• Number of securities for which 38 *quotation is sought
• 39 Class of *securities for which quotation is sought
• Do the *securities rank equally in all 40 respects from the date of allotment with an existing *elass of quoted *securities?

If the additional securities do not rank equally, please state:

• the date from which they do $\bullet$
• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend. distribution or interest payment
• 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security)
• Number and ⁺class of all ⁺securities 42 quoted on ASX (including the securities in clause $38$ )

Number	+ Class

⁺ See chapter 19 for defined terms.

Ouotation agreement

• $\mathbf{1}$ *Quotation of our additional *securities is in ASX's absolute discretion. ASX may quote the *securities on any conditions it decides.
• $\overline{2}$ We warrant the following to ASX.
• The issue of the *securities to be quoted complies with the law and is not for $\bullet$ an illegal purpose.
• There is no reason why those *securities should not be granted *quotation.
• An offer of the "securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any ٠ applications received by us in relation to any *securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the 'securities be quoted.
• We warrant that if confirmation is required under section 1017F of the $\bullet$ Corporations Act in relation to the *securities to be quoted, it has been provided at the time that we request that the "securities be quoted.
• If we are a trust, we warrant that no person has the right to return the $\bullet$ *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the "securities be quoted.

$+$ See chapter 19 for defined terms.

• We will indemnify ASX to the fullest extent permitted by law in respect of any $\overline{3}$ claim, action or expense arising from or connected with any breach of the warranties in this agreement.
• $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

Company Secretary

Date: 22 November 2005

Print name:

Phillip Hains

$= 1.42$

The CFO Solution www.thecfo.com.au 23 November 2005

$\div$ See chapter 19 for defined terms.